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Introduction
The centrosome is the main microtubule-organizing center of an-
imal cells and contributes to correct segregation of the genetic 
material by directing bipolar spindle assembly. The centrosome 
comprises two microtubule-based cylindrical centrioles embed-
ded in pericentriolar material (PCM; for review see Azimzadeh 
and Bornens, 2007; Marshall, 2009; Azimzadeh and Marshall, 
2010; Carvalho-Santos et al., 2010; Gönczy, 2012). A defining 
feature of centrioles is a ninefold radial symmetric arrangement 
of microtubules that is also imparted onto cilia and flagella that 
originate from them. Not surprisingly given their fundamental 
roles in multiple cellular processes, structural and functional 
aberrations of centrioles can cause human diseases, including 
ciliopathies, microcephaly, male sterility, and cancer (Nigg and 
Raff, 2009; Bettencourt-Dias et al., 2011).
In proliferating cells, a new procentriole assembles next to 
the proximal end of each parental centriole, approximately at 
the G1/S transition (Kuriyama and Borisy, 1981; Chrétien et al., 
1997). In most species, procentrioles form around the cart-
wheel, a structure 120 nm in diameter and 100 nm in height 
that is best visualized by EM in unicellular organisms (Dippell, 
1968; Cavalier-Smith, 1974). The cartwheel consists of a central 
hub 20–25 nm in diameter from which emanate nine spokes 
that exhibit a 40° angle between them and extend toward pe-
ripheral microtubules. Given its ninefold radial symmetry and 
appearance at the onset of procentriole formation, the cartwheel 
has been proposed to impart the defining arrangement of the 
entire centriole (reviewed in Strnad and Gönczy, 2008). Analy-
sis of mutants in cartwheel components, including members of 
the SAS-6 protein family, has validated such a role. For instance, 
the Chlamydomonas reinhardtii SAS-6 homologue Bld12p is 
 SAS-6 proteins are thought to impart the ninefold symmetry of centrioles, but the mechanisms by which their assembly occurs within cells remain elusive. In 
this paper, we provide evidence that the N-terminal, 
coiled-coil, and C-terminal domains of HsSAS-6 are each 
required for procentriole formation in human cells. More-
over, the coiled coil is necessary and sufficient to mediate 
HsSAS-6 centrosomal targeting. High-resolution imaging 
reveals that GFP-tagged HsSAS-6 variants localize in a 
torus around the base of the parental centriole before 
S phase, perhaps indicative of an initial loading platform. 
Moreover, fluorescence recovery after photobleaching 
analysis demonstrates that HsSAS-6 is immobilized pro-
gressively at centrosomes during cell cycle progression. 
Using fluorescence correlation spectroscopy and three- 
dimensional stochastic optical reconstruction microscopy, 
we uncover that HsSAS-6 is present in the cytoplasm pri-
marily as a homodimer and that its oligomerization into 
a ninefold symmetrical ring occurs at centrioles. Together, our 
findings lead us to propose a mechanism whereby HsSAS-6 
homodimers are targeted to centrosomes where the local 
environment and high concentration of HsSAS-6 promote 
oligomerization, thus initiating procentriole formation.
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Figure 1. Domains of HsSAS-6 mediating centrosomal targeting and duplication. (A–U) U2OS (A–C) and iU2OS (D–U) cells in S phase (left) or mitosis 
(prometaphase/metaphase; right) expressing HsSAS­6 variants and stained for HsSAS­6 (A–C) or GFP (D–U) and centrin­3 as well as EdU to mark S­phase 
cells (left column). Schematics indicate the domains and amino acid boundaries of the variants. Doxycycline induction for 48 h was concomitant with siHsSAS­6 
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cytoplasmic protein pool (Strnad et al., 2007; Puklowski et al., 
2011). Importantly, mutation of the F131 residue abrogates the 
function of HsSAS-6 in procentriole formation, consistent with 
oligomerization being critical in human cells as well (Kitagawa 
et al., 2011).
Despite these advances, many important questions remain 
regarding the mechanisms of action of HsSAS-6 in human 
cells. In particular, the domains of HsSAS-6 needed for target-
ing the protein to centrosomes as well as for sustaining centriole 
formation in vivo are not known. Moreover, the oligomeriza-
tion state of HsSAS-6 within the cytoplasm and whether the 
protein assembles into a ringlike structure at the centrosome 
has not been determined.
Results
Identification of HsSAS-6 domains 
important for centrosomal targeting  
and function
We set out to determine the domains of HsSAS-6 mediating 
centrosomal targeting and those required for centriole formation. 
We generated U2OS cells expressing doxycycline-inducible 
EGFP-tagged (hereafter referred to as GFP) HsSAS-6 truncation 
variants to assess the contribution of the N-terminal (N), coiled-
coil (C-C), and C-terminal (C) domains (Fig. 1). We also depleted 
endogenous HsSAS-6 using siRNAs directed against the 3UTR, 
which is absent from the GFP fusion constructs (Fig. S1).
We analyzed cells in S phase, recognized by 5-ethynyl-2-
deoxyuridine (EdU) incorporation, and cells in prometaphase/
metaphase (hereafter collectively referred to as mitosis), which 
were recognized by their condensed DNA. Cells were examined 
by immunofluorescence with antibodies against centrin to mark 
centrioles and against GFP to monitor the fusion proteins. As 
previously reported (Kitagawa et al., 2011), a full-length (FL) 
HsSAS-6 with a C-terminal GFP (FL-GFP) localizes to centro-
somes in S phase and in mitosis, recapitulating the distribution 
of endogenous HsSAS-6 (Fig. 1, A, B, D, and E). An HsSAS-6 
variant with an N-terminal GFP (GFP-FL) behaves similarly, 
though fewer cells can be analyzed because of aggregation of 
this fusion protein (unpublished data). Moreover, we found that 
neither GFP-N nor GFP-C localizes to centrosomes (Fig. 1, G, 
H, M, and N), whereas GFP–C-C is present at centrosomes in 
100% of S-phase cells (Fig. 1 J) but in only in 7% of mitotic 
cells (Fig. 1 K). Cells expressing constructs with either the N- or 
C-terminal domain added to the coiled coil (GFP-NL and GFP-CL, 
respectively) behave similarly to GFP–C-C (Fig. 1, P, Q, S, and T). 
Because an HsSAS-6 variant lacking 90% of the coiled coil 
exhibits little or no centrosomal localization (van Breugel et al., 
2011), we conclude that the coiled coil is necessary and suffi-
cient for recruiting HsSAS-6 to centrosomes. Our data also 
required for cartwheel assembly and efficient centriole for-
mation (Nakazawa et al., 2007). The few remaining basal bod-
ies in Bld12p-null mutants exhibit radial symmetries that differ 
from the canonical ninefold (Nakazawa et al., 2007), thus 
highlighting the crucial role of Bld12p in establishing the nine-
fold symmetry of the cartwheel and ensuring robust procentri-
ole assembly.
Proteins of the SAS-6 family harbor a globular N-terminal 
head, followed by a coiled-coil domain and a C-terminal tail 
predicted to be unstructured and whose function is poorly un-
derstood (Leidel et al., 2005; Kitagawa et al., 2011; van Breugel 
et al., 2011). Biophysical analyses of fragments of Caenorhab-
ditis elegans SAS-6 and C. reinhardtii Bld12p established that 
the coiled-coil domain drives homodimerization of SAS-6 pro-
teins, with a Kd of 1 µM (Kitagawa et al., 2011). Moreover, 
rotary metal shadowing EM of SAS-6 and Bld12p fragments 
demonstrated that homodimers of SAS-6 proteins harbor globular 
heads followed by elongated rods corresponding to the coiled-
coil moiety (Kitagawa et al., 2011). Finally, the crystal structure 
of the head domain of SAS-6 proteins from C. elegans, C. rein-
hardtii, and Danio rerio revealed the importance of a residue 
(corresponding to F131 in the human homologue HsSAS-6) in 
mediating interaction between two head domains from adjacent 
homodimers (Kitagawa et al., 2011; van Breugel et al., 2011), 
with a Kd of 50 µM for HsSAS-6 (van Breugel et al., 2011). 
This interaction drives the formation of higher order oligomers 
of homodimers, hereafter referred to as oligomers. In the case 
of Bld12p, these oligomers are seen by rotary metal shadowing 
EM as V-shaped tetramers as well as ringlike structures from 
which the coiled-coil domains emanate (Kitagawa et al., 2011). 
These rings exhibit a diameter of 22 nm, consistent with that 
of the cartwheel hub observed in situ, whereas the angle between 
two coiled-coil rods of tetramers is 42°, consistent with a nine-
fold symmetry (Kitagawa et al., 2011). These studies suggest a 
mechanism whereby self-assembly of SAS-6 proteins can lead 
to the formation of a ninefold symmetrical structure resembling 
the cartwheel (Kitagawa et al., 2011; van Breugel et al., 2011). 
Compatible with such a mechanism, analysis of the elongated 
cartwheel of Trichonympha sp. by cryoelectron tomography re-
vealed stacks of rings that could accommodate oligomers of 
nine SAS-6 homodimers (Guichard et al., 2012).
In cycling human cells, depletion of HsSAS-6 results in a 
failure of centriole formation, whereas its overexpression leads 
to supernumerary centrioles (Leidel et al., 2005; Strnad et al., 
2007). HsSAS-6 is one of the earliest proteins recruited at the 
onset of procentriole assembly and is present in the proximal, 
cartwheel-bearing, region of the procentriole until metaphase 
(Kleylein-Sohn et al., 2007; Strnad et al., 2007; Sonnen et al., 2012; 
Lukinavičius et al., 2013). Thereafter, centrosomal HsSAS-6 
is degraded in an APC (anaphase-promoting complex)- and 
SCF (Skp1–Cullin–F-box)-dependent manner, along with the 
3UTR (siUTR) treatment. Percentage of HsSAS­6–positive centrosomes (indicated at bottom right of images) was assessed both in EdU­positive and mitotic 
cells. Histograms report mean frequency of mitotic cells with at least four centrioles in control (ctrl) U2OS cells and siRNA­treated cells (siUTR). Data are 
from at least two experiments; error bars show standard deviations; number of cells analyzed are given in Table S1. Note that the C­terminal domain on 
top of the coiled coil (CL) augments the fraction of EdU­negative cells exhibiting centriolar signal. Insets are magnified regions of the boxed areas. Bars: 
(main images) 10 µm; (insets) 1 µm.
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Cep152) centriolar markers. This analysis revealed that the 
F131E-GFP torus is located at the proximal end of the parental 
centriole (Fig. 2, G–J), largely coinciding with Cep152 and 
Pericentrin (Lawo et al., 2012; Sonnen et al., 2012). A similar 
localization was found in cells expressing FL-GFP (Fig. S2, K–N). 
Furthermore, we found that depletion of Cep152 results in a 
lack of torus (Fig. 2, E and K–N), establishing that Cep152 is 
needed for HsSAS-6 torus formation. To characterize this torus 
with further precision, we turned to 3D stochastic optical re-
construction microscopy (STORM), using a depth-independent 
imaging protocol enabling 35-nm lateral and 50-nm axial 
resolutions (Olivier et al., 2013b). This allowed us to determine 
that the torus is 432 ± 12 nm in diameter (Fig. 2, O–R). Over-
all, we conclude that GFP-tagged HsSAS-6 proteins can local-
ize around the proximal end of the parental centriole, raising 
the possibility that the endogenous protein also transits through 
that location.
HsSAS-6 centrosomal dynamics
To determine whether HsSAS-6 is immobilized after its initial 
recruitment to the centrosome, we performed FRAP experiments 
and quantified the exchange between centrosomal and cytoplas-
mic pools of HsSAS-6. We generated a U2OS cell line expres-
sing tagRFP-centrin in addition to the functional FL-GFP. We 
conducted these experiments both in early S phase, at the onset 
of procentriole formation, and in late G2, when procentriole 
formation is completed (Fig. S3, E and F). Cells were synchro-
nized using a double-thymidine block and imaged by dual-color 
confocal microscopy. Experiments performed with or without 
the endogenous protein were indistinguishable (Fig. S3, G and H), 
and the two datasets were therefore pooled for analysis.
We found that in early S phase, 60% of the initial fluor-
escence intensity of centrosomal FL-GFP recovers within 45 min, 
with a t1/2 of 8.5 ± 1 min (Fig. 3, A and C). Therefore, 40% of 
centrosomal HsSAS-6 does not exchange with the cytoplasmic 
pool within this time frame, indicating that these molecules are 
immobilized. In late G2, only 25% of the initial centrosomal 
fluorescence intensity recovers within 45 min, with a similar t1/2 
to the one in S phase (Fig. 3, B and C), indicating that 75% of 
HsSAS-6 is now immobilized at centrosomes.
We addressed whether this progressive immobilization is 
accompanied by an increase in the size of the underlying structure. 
3D-STORM imaging on S–G2 and late G2 cells after detergent 
extraction to retain the most stably incorporated molecules re-
vealed that the mean length of HsSAS-6–positive structures is 
60 nm in early S phase and 150 nm in late G2 (Fig. 3, D–K).
Overall, these experiments establish that there is substan-
tial recruitment of HsSAS-6 from the cytoplasm to centrosomes 
at the onset of S phase. More HsSAS-6 is then immobilized at cen-
trosomes as cells progress through the cell cycle, which leads to an 
increase in the size of a stable HsSAS-6–containing structure.
Spatial and temporal distribution  
of HsSAS-6
Previous qualitative observations suggested that overall cellu-
lar levels of HsSAS-6 are low in G1 and increase gradually as 
cells progress through S phase and G2, whereas the signal at 
reveal that both N- and C-terminal domains are required for the 
persistence of centrosomal HsSAS-6 until mitosis.
We next addressed whether the HsSAS-6 variants are func-
tional by determining the number of centrin foci in mitotic cells. 
In control conditions, 95% of cells have at least four centrin 
foci (Fig. 1 C). Depletion of endogenous HsSAS-6 results in 
only 10% of cells having at least four centrin foci, a pheno-
type rescued to 85% by FL-GFP (Fig. 1, C and F). As shown 
in Fig. 1, no other variant rescues the depletion of endogenous 
HsSAS-6. Although the requirements of the N-terminal and of 
the coiled-coil domains were expected (Kitagawa et al., 2011; 
van Breugel et al., 2011), our findings uncover that the C-terminal 
domain is also essential for HsSAS-6 function.
HsSAS-6 variants localize in a torus 
around the proximal end of the  
parental centriole
In performing these experiments, we noted that S-phase cells 
expressing GFP–C-C, GFP-NL, or GFP-CL often exhibit a 
broader, toruslike, centrosomal signal (Fig. 1, J, P, and S). This 
observation was confirmed by examining single confocal sec-
tions (Fig. 2, A–C). Because these variants do not sustain cen-
triole formation, this distribution could reflect a transient 
localization revealed by nonfunctional proteins being trapped 
during the assembly process. Indeed, we found such a torus in 17% 
of cells expressing the oligomerization-defective HsSAS-6–
[F131E] (F131E-GFP) variant, with the remaining cells having 
weak or no signal at centrosomes (Fig. 2, D–E). A torus is also 
detectable in a smaller fraction (9%) of cells expressing FL-GFP, 
although most cells exhibit a focused signal, presumably corre-
sponding to the protein being incorporated in the cartwheel 
(Fig. 2 E). These results establish that a torus can be observed with 
a functional version of HsSAS-6. However, we failed to detect a 
torus using antibodies against endogenous HsSAS-6, possibly be-
cause higher protein levels, as observed upon FL-GFP expression, 
are needed to detect what may be a very transient localization.
We set out to determine when during the cell cycle such a 
torus first appears. We synchronized cells expressing FL-GFP 
using mitotic shake off and examined them at successive time 
points thereafter for the presence of a torus and the S-phase marker 
proliferating cell nuclear antigen (PCNA). We found that the fre-
quency of cells with a torus increases steadily during G1, peak-
ing 5–6 h after mitosis (Fig. 2 F). We conclude that the torus 
can form during the G1 phase of the cell cycle. Importantly, we 
found a similar profile upon depletion of endogenous HsSAS-6 
(Fig. S2, A and B). Given that centriole duplication in such cells 
relies on the GFP-tagged protein (Fig. 1, C and F), this finding 
reinforces the notion that the torus may recapitulate a transient 
behavior of endogenous HsSAS-6. In line with its transient nature, 
we found that detergent extraction leads to the complete loss of 
the torus in cells expressing F131E-GFP, whereas the focused 
signal of cells expressing FL-GFP remains, as anticipated from the 
protein being stably incorporated in the cartwheel (Fig. S2, C–J).
To address where within the centrosome this torus resides, 
we conducted confocal imaging of cells expressing F131E-GFP 
labeled with antibodies against GFP as well as against known 
distal (centrin or CP110) and proximal (c-Nap1, Pericentrin, or 
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Figure 2. HsSAS-6 variants accumulate in a torus around the proximal end of the parental centriole. (A–D) Brightness/contrast­adjusted single planes 
of confocal images of GFP–C­C, GFP­CL, GFP­NL, and F131E­GFP at centrosomes showing the torus taken from iU2OS cells induced with doxycycline 
for 48 h concomitant with siHsSAS­6 3UTR treatment, fixed, and stained for GFP, centrin­2, and DNA. Insets are magnified regions of the boxed areas. 
(E) Asynchronous population of cells expressing FL­GFP, F131E­GFP, or F131E­GFP depleted of Cep152 (siCep152) stained for GFP and centrin­2. Maximal 
projection images illustrate distinct GFP distributions at centrosomes (left), whereas the graph reports their occurrence (right). Error bars show standard error 
of the mean. Number of cells from at least two experiments: 440 for FL­GFP, 231 for F131E­GFP, and 263 for F131­GFP siCep152. (F) Time course in cells 
expressing FL­GFP, synchronized by mitotic shake off, and stained for GFP, centrin­2 and Pericentrin, or GFP and PCNA reveals increase in the torus­bearing 
fraction as cells exit mitosis and progress through G1. Error bars show standard error of the mean. Number of cells analyzed and statistical analysis 
are given in Table S2. (G–J) Centrosomes labeled with GFP, centrin­2 (G, H, and J), or CP110 (I) and Pericentrin (H), cNap­1 (I), or Cep152 (J) illustrate 
F131E­GFP torus localization at the proximal end of parental centrioles with corresponding schematics on the right. Dotted box and circle in G represent 
the orientation of centrioles. (K–N) Depletion of Cep152 abolishes F131E­GFP torus localization around the parental centriole. n = 253 for control and 263 
for siCep152. (O–R) 2D projections along the indicated axes of 3D­STORM images of F131E­GFP–expressing cells treated with siHsSAS­6 3UTR reveal 
a torus with a mean radius of 216 ± 12 nm (n = 6). Arrowhead, area with fewer molecules. Bars: (A–D [main images], K, and M) 10 µm; (A–D [insets], 
L, and N) 1 µm; (E and G–J) 500 nm; (O–Q) 200 nm.
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Figure 3. HsSAS-6 is progressively immobilized at centrosomes during the cell cycle. (A and B) Cells expressing low to medium levels of HsSAS­6–GFP were 
selected in early S phase (A) or late G2 (B) according to their centriolar configurations (Fig. S3, E and F), photobleached, and monitored thereafter for signal 
recovery. Note that given the resolution limit of confocal microscopy, no distinction can be made between pericentriolar, centriolar, or procentriolar signals. 
Insets are magnified regions of the boxed areas. (C) Recovery of centrosome­associated fluorescence from cells in early S phase (n = 8) or late G2 (n = 9), 
with 100% corresponding to prebleach intensity values, and 0% corresponding to those immediately after bleach (t0); error bars show standard deviations. 
Recovery curves were fitted with a single exponential function; maximum recovery amplitudes, A, and times at half­maximal recovery, t1/2, are indicated. 
Note that no correlation was found between levels of expression and extent of recovery among the cells analyzed. (D–H) Representative 3D­STORM images 
of centrosomal HsSAS­6 in S–G2 (D and E) and late G2 (G and H). Side view of HsSAS­6–containing structures shown in the indicated projections and 
the localization of parental and nascent centrioles (dashed yellow boxes) obtained from wide­field centrin images before STORM imaging was used to 
determine the length axis and quantify (F and I) the signal intensity along this axis using a line profile (arrows indicate direction; Materials and methods and J). 
The apparent double focus in D and E is expected from a projection of the underlying HsSAS­6 ring (Fig. 6). (J and K) Quantification of lengths (J) and 
volumes (K) of HsSAS­6–positive structures in 3D­STORM images reveals a significant increase from S to G2 (n = 12 for S phase, and n = 18 for G2; P < 
0.0001 for both J and K). Error bars show means and standard deviations; values from individual structures are shown as circles or squares. AU, arbitrary 
unit; FWHM, full width at half­maximum. Bars: (A and B, main images) 10 µm; (A and B, insets) 1 µm; (D and G) 500 nm; (E and H) 100 nm.
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within centrosomal subvolumes provides a mechanism driv-
ing oligomerization.
HsSAS-6 oligomerization state
The oligomerization state of SAS-6 proteins has not been directly 
ascertained in vivo. We addressed this question by conducting 
fluorescence correlation spectroscopy (FCS) in the cytoplasm of 
live cells depleted of endogenous HsSAS-6 and expressing either 
FL-GFP, F131E-GFP, or GFP-C, which is expected to be strictly 
monomeric in the absence of the coiled-coil domain (Kitagawa 
et al., 2011; van Breugel et al., 2011). In FCS experiments 
(Bulseco and Wolf, 2007; Chen et al., 2008), fluctuations in fluor-
escence intensity are monitored as molecules pass through the 
observation volume (Fig. 5 A, i and ii). These fluctuations are 
correlated over time, yielding an autocorrelation function (ACF; 
Fig. 5 A, iii and iv), which is then fitted to diffusion models and 
yields the mean number N of molecules in the observation vol-
ume, their brightness (counts per molecule [CPM]), and their dif-
fusion coefficients. From these parameters, the oligomerization 
state of molecules can be directly extracted.
All the ACF curves could be fitted to a model for single 
component anomalous diffusion (Materials and methods; Fig. 5, 
B and C). Although the presence of low-abundant additional spe-
cies cannot be excluded, this analysis suggests that all HsSAS-6 
variants analyzed diffuse primarily as a single component, indi-
cating that they each likely behave as a single macromolecular 
species. We also assessed the brightness detected for each protein, 
which is directly extracted from the fluorescent traces (Fig. 5 A, ii) 
and thus independent of the mathematical model used to fit the 
data. We used constructs carrying one or two copies of GFP to 
calibrate these values. As shown in Fig. 5 E, cells expressing 
GFP–GFP have twice the normalized brightness of those ex-
pressing single GFP and exhibit a lower diffusion coefficient, as 
expected from a larger protein (Fig. 5 F).
We found that GFP-C has a mean brightness similar to 
that of monomeric GFP (Fig. 5 E), and its diffusion coefficient 
is analogous to that of the similarly sized GFP–GFP (Fig. 5 F). 
These results establish that GFP-C exists mainly as a monomer 
in the cytoplasm. Furthermore, we found that FL-GFP and 
F131E-GFP exhibit similar brightness, 1.6 times that of mo-
nomeric GFP, and similar diffusion times (Fig. 5, E and F). 
These results demonstrate that FL-GFP and F131E-GFP exist 
in complexes in the cytoplasm that do not differ significantly in 
terms of their hydrodynamic radius. The 1.6-fold increased 
brightness of both FL-GFP and F131E-GFP as compared with 
GFP raises the possibility that both species are present in a mix-
ture consisting predominantly of HsSAS-6 homodimers (bright-
ness of two GFP) and of monomers (brightness of single GFP), 
thus leading to an intermediate brightness; in this case, both 
species should be described by a two-component diffusion model. 
However, we favor the alternative view whereby association of 
a GFP-tagged protein with residual untagged endogenous 
HsSAS-6 forms a dimer with the brightness of a single GFP, 
thus reducing the overall mean brightness. Moreover, quench-
ing between two close GFP molecules at the C terminus of 
HsSAS-6 may also decrease the fluorescence exhibited by bona 
centrosomes becomes readily detectable in early S phase and is 
present until metaphase (Strnad et al., 2007). We quantified total 
cellular fluorescence intensity using antibodies against endoge-
nous HsSAS-6 and found no difference between G1 and early S, 
a 2.5-fold increase as cells progress into S phase and G2, and 
a further approximately twofold increase as they reach late G2 
(Fig. 4, A–E). In addition, we found that HsSAS-6 is clearly en-
riched at centrosomes starting in early S phase and increases 
approximately twofold as cells progress into S and G2 and a 
further approximately twofold by late G2 (Fig. 4, A–D and F).
We set out to estimate the molarity of HsSAS-6 in the 
cytoplasm and at centrosomes, notably to evaluate whether the 
protein could readily undergo homodimerization or oligomer-
ization in either location. To estimate the total amount of HsSAS-6 
per cell, we performed Western blot analysis of lysates from an 
asynchronous population and compared the resulting signal in-
tensity to that of known concentrations of recombinant protein. 
We determined that U2OS cells contain on average 0.05 pg 
HsSAS-6 per cell. Similar values were obtained for KE-37 cells 
(Materials and methods; Fig. 4, G–I). We then estimated the cy-
toplasmic molarity by considering the distribution of cells in 
each phase of the cell cycle and the fluorescence intensity for 
each phase (Materials and methods; Fig. 4 E), yielding concen-
trations of 0.08 µM in early S and 0.36 µM in late G2 
(Fig. 4 J). These values are below the Kd required for homodi-
merization of related SAS-6 proteins in vitro (1 µM; Kitagawa 
et al., 2011; van Breugel et al., 2011) and well below that needed 
for oligomerization of HsSAS-6 N-terminal domains (50 µM; 
van Breugel et al., 2011).
We sought to estimate centrosomal HsSAS-6 molarity ini-
tially using the total centrosomal fluorescence intensity deter-
mined at specific stages of the cell cycle (Fig. 4 F) and considering 
as a volume the optical resolution of the confocal microscope 
(0.2 µm3; Fig. 4 J). This analysis yields concentrations of 
 16 µM and 66 µM in early S and late G2, respectively. Be-
cause centrosomal concentrations depend significantly on the 
volume considered, we also estimated the centrosomal molarity 
using two volume-independent approaches. First, we conducted 
Western blot analysis of centrosomes purified from asynchro-
nously growing KE-37 cells and estimated that HsSAS-6 is 
100-fold more concentrated at centrosomes compared with 
the cytoplasm (Materials and methods; Fig. 4 G). Second, we 
estimated by immunofluorescence the fold increase of the cen-
trosomal signal over the cytoplasmic signal to be 90 in an 
asynchronous population of U2OS cells (n = 42; Materials and 
methods). These two estimates concur to indicate that the mean 
molarity of HsSAS-6 at centrosomes is 8 µM in early S and 
36 µM in late G2 (Fig. 4 J). These values are in the same range 
as those estimated initially and are high enough to enable homodi-
merization of HsSAS-6 proteins. Moreover, given that HsSAS-6 
may be more concentrated within certain centrosomal subvol-
umes, such as that observed in early S phase (Fig. 3, E and F), 
it is possible that the effective molarity in such subvolumes 
is high enough for oligomerization (Discussion). Overall, 
these experiments lead us to conclude that levels of centro-
somal HsSAS-6 augment significantly between early S and 
late G2 and raise the possibility that concentration of HsSAS-6 
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Figure 4. HsSAS-6 cytoplasmic and centrosomal distributions across the cell cycle. (A–D) U2OS cells synchronized by mitotic shake off, fixed, and stained 
at different time points thereafter for HsSAS­6, centrin­3, and DNA. Cells were binned into the indicated cell cycle stages according to centrin and HsSAS­6 
configurations plus DNA condensation (Fig. S3, A–D; Materials and methods). Insets are magnified regions of the boxed areas. (E and F) Total cellular (E) 
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organization from algae to man. The finding that SAS-6 protein 
fragments can self-assemble in vitro into a structure that resem-
bles the cartwheel has led to a model whereby this family of 
proteins is critical for establishing the ninefold symmetry of 
centrioles (reviewed in Gönczy, 2012). Many questions re-
mained open at the onset of our work regarding the mecha-
nisms by which this protein operates in vivo. Our analysis has 
uncovered a series of steps that lead from HsSAS-6 being 
present in the cytoplasm to its incorporation into a ninefold 
symmetrical structure during procentriole formation. These steps 
are discussed in this section and represented schematically 
in Fig. 7.
Cytoplasmic homodimerization: A first step 
in the assembly process
Considering that the coiled coil of C. elegans SAS-6 and of 
C. reinhardtii Bld12p homodimerizes with a Kd of 1 µM in vitro 
(Kitagawa et al., 2011) and that our estimates based on Western 
blotting, immunofluorescence, and FCS indicate that the con-
centration of HsSAS-6 in the cytoplasm is on the order of 0.08–
0.36 µM, one would have expected cytoplasmic HsSAS-6 to be 
monomeric. However, our FCS measurements indicate that a 
significant fraction of cytoplasmic HsSAS-6 is homodimeric. 
Perhaps the Kd for the complete FL HsSAS-6 is lower than that 
measured for the SAS-6 and Bld12p fragments lacking the tail 
domain (Kitagawa et al., 2011; van Breugel et al., 2011) or else 
HsSAS-6 homodimerization could be aided in the cell by other 
proteins or an increased effective local concentration in the 
crowded cytoplasmic environment. Our findings using FCS es-
tablish also that HsSAS-6 oligomerization does not occur in 
a detectable manner in the cytoplasm, as expected given that 
the Kd between HsSAS-6 head domains in vitro is 50 µM 
(van Breugel et al., 2011). In contrast, DmSas-6 molecules assem-
ble as tetramers in Drosophila melanogaster embryonic extracts 
(Gopalakrishnan et al., 2010), suggesting that the status of SAS-6 
proteins in the cytoplasm differs between species or cell types. 
In some cases, multiple procentrioles can also assemble de novo 
in the cytoplasm of mammalian cells, as in differentiated multi-
ciliated epithelial cells (Vladar and Stearns, 2007). In such a 
situation, it is possible that HsSAS-6–containing cartwheel inter-
mediates or preassembled cartwheels exist in the cytoplasm, 
perhaps as a result of substantial increase in HsSAS-6 gene ex-
pression (Hoh et al., 2012).
fide marked homodimers. Finally, we noted that the FCS mea-
surements yield cytoplasmic concentrations of 0.1 µM of 
FL-GFP and F131E-GFP in the focal volume, which are in the 
range of those extracted for endogenous HsSAS-6 (Fig. 4). In 
conclusion, these findings reveal that wild-type and oligomerization-
defective F131E mutant HsSAS-6 molecules have an indis-
tinguishable behavior and exist predominantly as homodimers in 
the cytoplasm.
Centriolar HsSAS-6 is distributed in a 
ninefold radially symmetric manner
We wanted to address whether ring formation of HsSAS-6 oc-
curs in the cartwheel of procentrioles in human cells. As FCS 
is restricted to monitoring proteins that are mobile and at low 
concentration, we turned to STORM microscopy to investigate 
HsSAS-6 distribution in situ. These experiments were performed 
in detergent-extracted cells so as to retain primarily the immobile 
centriolar fraction.
Because centrioles exhibit a variety of orientations, we 
took advantage of a buffer-enhanced 3D-STORM approach that 
enables near-isotropic lateral and axial resolutions (Olivier 
et al., 2013a). We analyzed cells synchronized by mitotic shake 
off, focusing on early S phase and thus on the early stages of 
procentriolar formation (Fig. S3, A–C). To best determine the 
organization of HsSAS-6 assemblies and their underlying sym-
metry, we used a monoclonal antibody directed against the 
C-terminal domain of HsSAS-6 (Fig. S1) labeled with Alexa 
Fluor 647 antibodies. Strikingly, we found that HsSAS-6 mole-
cules are distributed in ringlike patterns with a mean radius of 
45 ± 3 nm (Fig. 6 A). This allowed us to localize for the first 
time HsSAS-6 C termini within the centriole (Fig. 6 C). Im-
portantly, we found that the angular distribution of the signal 
intensities exhibits a period of 42 ± 8° (Fig. 6 B and Fig. S4), 
consistent with the values published previously for in vitro as-
semblies (Kitagawa et al., 2011). These results strongly support 
the notion that N–N interaction and ring formation occurs at 
centrioles in human cells and that HsSAS-6 exhibits a ninefold 
symmetric arrangement in its cellular context (Fig. 6 C).
Discussion
How the defining ninefold radial symmetry of centrioles is es-
tablished has been a long-standing question in cell biology. The 
cartwheel plays a critical role in imparting this remarkable 
and centrosomal (F) HsSAS­6 fluorescence intensity. Box plots represent lower and upper quartiles and median values as well as the means (full squares) 
and standard deviations, and crosses indicate minimum and maximum values. Statistical analysis: p­values and cell numbers are reported in Table S3 and 
Table S4. (G–J) Estimation of HsSAS­6 molarity in the cytoplasm and at centrosomes. (G) Increasing amounts of whole­cell lysates from KE­37 or U2OS cells 
compared with increasing amounts of recombinant HsSAS­6 (r. HsSAS­6) by Western blotting using HsSAS­6 antibodies. Proteins from purified centrosomes 
of asynchronous KE­37 cells (centrosome prep, CTM) were loaded in parallel to recombinant HsSAS­6. (H, left) Purified BSA and HsSAS­6 proteins were 
stained with Coomassie blue and quantified with GelEval software. The correlation between the indicated amounts of purified HsSAS­6 and the values 
obtained with GelEval is displayed on the right. Boxes define the areas taken for signal intensity measurements of BSA and HsSAS­6. (I) Increasing amounts 
of KE­37 and U2OS cells were lysed and the protein concentration corresponding to each lysate determined. The correlation between the cell number used 
and the respective total protein recovered is indicated. (H and I) Vertical lines indicate standard deviation. (J) Approximate number of HsSAS­6 molecules 
in the cytoplasm of early S, S–G2, and late G2 cells estimated using the mean total fluorescence intensity at these stages (E and F) and a conversion factor 
linking estimates by Western blotting and immunofluorescence, rounded up to the nearest 1,000, and the corresponding cellular molarity using a volume 
of 4,000 µm3 for U2OS cells (Beck et al., 2011). The apparent centrosomal molarity was estimated using centrosomal HsSAS­6 intensities from F and a 
volume of 0.2 µm3 (optical resolution limit); mean centrosomal molarities were estimated using fold enrichment values determined from KE­37 purified cen­
trosomes (100×; CTM prep) or from U2OS immunofluorescence (images [90×; CTM (IF)]). See Materials and methods for calculation details. AU, arbitrary 
unit. Bars: (main images) 10 µm; (insets) 1 µm.
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Figure 5. FCS analysis of cytoplasmic HsSAS-6. (A) Schematics of FCS measurements: intensity fluctuations of fluorescent molecules in the observation 
volume (i) are recorded over time (ii), analyzed using an autocorrelation function (iii), and plotted as a function of the delay times , thus yielding the 
characteristic diffusion time D linked to the diffusion coefficient (Bulseco and Wolf, 2007; Chen et al., 2008). FCS analysis was performed with iU2OS 
stably expressing FL­GFP, F131E­GFP, GFP­C, or GFP–GFP as well as on U2OS cells transiently transfected with a GFP construct; endogenous HsSAS­6 was 
depleted concomitantly to induction of FL­GFP, F131E­GFP, and GFP­C expression for 48 h, and low­ to medium­expressing cells were selected to avoid 
overexpression artifacts. (B) Single representative FCS curves and their fit for GFP, FL­GFP, and F131E­GFP. Note that lag times <10 µs were clipped from 
the graph as they represent intramolecular events rather than protein diffusion coefficients (Bulseco and Wolf, 2007). (C) R2 values from one­component 
anomalous diffusion fittings of the different constructs indicate that this model is a good approximation of the experimental data. Values of individual fits, 
calculated means (indicated above), and standard deviations are shown. (D) The mean molecule number extracted from the FCS curve fit indicates that 
all observation volumes contained comparable numbers of fluorescent proteins (mean values indicated above). (E and F) Normalized brightness (E) and 
characteristic diffusion coefficients (F) are shown (Materials and methods) as well as individual fit values, calculated means (indicated above), and standard 
deviations. Cell number from three experiments and statistical analysis are reported in Table S5 and Table S6. Note that no correlation was found between 
number of molecules detected within a focal volume (concentration) and the diffusion coefficient or brightness values, indicating that higher expression did 
not lead to detectable oligomeric species. A.U., arbitrary unit.
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localization (Leidel et al., 2005). Moreover, SAS-5 exchanges 
readily between the cytoplasm and centrosomes and was pro-
posed to target SAS-6 to centrosomes (Leidel et al., 2005). 
STIL recapitulates several features of SAS-5, being required for 
centriole duplication and shuttling rapidly between cytoplasm 
and centrosomes; furthermore, HsSAS-6 and STIL colocalize at 
procentrioles and appear to be mutually dependent for their lo-
calization (Arquint et al., 2012; Vulprecht et al., 2012). How-
ever, no direct interaction has been found between STIL and 
HsSAS-6 (Vulprecht et al., 2012; Lukinavičius et al., 2013), in-
dicating that the relationship between the protein pairs might 
differ between C. elegans and human cells. Another candidate 
to target HsSAS-6 centrosomal localization is Cep135. Indeed, 
an interaction has been detected between the C-terminal domain 
of Cep135 and parts of the HsSAS-6 coiled-coil and tail do-
mains (Lin et al., 2013). However, cells depleted of Cep135 re-
tain HsSAS-6–positive procentrioles in S phase, suggesting that 
Cep135 is dispensable for the initial steps of HsSAS-6 centro-
somal recruitment (Lin et al., 2013).
A recruitment platform for HsSAS-6 
around the parental centriole?
Further insight into the mechanisms targeting HsSAS-6 to cen-
trosomes is suggested by our finding of a torus at the proximal 
end of the parental centriole in cells expressing GFP-tagged 
variants of the protein. We show that this localization is labile 
and depends on the presence of Cep152, a protein known to 
mediate the centriolar localization of the core centriolar pro-
teins Plk4 and CPAP (centrosomal protein 4.1–associated pro-
tein)/SAS-4, both in human (Cizmecioglu et al., 2010; Hatch 
et al., 2010) and Drosophila (Dzhindzhev et al., 2010). Al-
though the torus localization cannot be captured with endogenous 
HsSAS-6, perhaps because of its extremely transient nature, we 
propose that it reflects a recruitment platform for HsSAS-6. 
Interestingly, Cep152 localizes to a torus 400 nm in diameter 
around the parental centriole already in G1 (Cizmecioglu et al., 
2010; Hatch et al., 2010; Lawo et al., 2012), such that it could 
promote HsSAS-6 recruitment to this site before S phase. The 
presence of a torus in cells expressing F131E-GFP is reminis-
cent of results in C. elegans in which oligomerization-defective 
SAS-6 is targeted to centrosomes but cannot be incorporated in 
the procentriole thereafter (Lettman et al., 2013). Intriguingly, 
recent evidence in human cells indicates that Plk4 also exhibits 
a toroid distribution early in G1, overlapping with the Cep152 
torus (Kim et al., 2013). Moreover, Plk4 concentrates thereafter 
to a single position; because a region with less signal could be 
observed in the F131E-GFP torus, (Fig. 2 P, arrowhead), similar 
to that observed with Pericentrin (Lawo et al., 2012), it will be 
interesting to address whether this coincides with the Plk4 focus 
and perhaps marks the site of procentriole assembly.
Cartwheel assembly: HsSAS-6 
oligomerization
Once recruited to centrosomes, HsSAS-6 homodimers presum-
ably undergo oligomerization, either within the torus or the 
elongating cartwheel. Our estimates indicate that the apparent 
mean molarity of HsSAS-6 at centrosomes is 8 µM in early 
Centrosomal recruitment: Targeting 
HsSAS-6 to the right place
Around the G1/S transition, HsSAS-6 becomes clearly de-
tectable at centrosomes. Together with earlier findings (van 
Breugel et al., 2011), our work demonstrates that the coiled coil 
of HsSAS-6 is necessary and sufficient for centrosomal target-
ing. Given that coiled-coil domains often mediate protein–protein 
interactions, HsSAS-6 centrosomal targeting could be achieved 
through interaction with a partner protein. A plausible candidate 
is STIL, the human relative of C. elegans SAS-5 and Drosoph-
ila Ana2 (Stevens et al., 2010). In C. elegans, SAS-6 and SAS-5 
physically interact and are mutually dependent for their centriolar 
Figure 6. Centriolar HsSAS-6 is distributed with a ninefold radial sym-
metry. (A, left) 2D projection (sum of intensities) along the indicated 
axes of 3D­STORM images of HsSAS­6 rings in S­phase cells, preex­
tracted, and fixed with either PFA (A1) or methanol (A3) and stained with 
C­terminal–specific antibodies (Fig. S2). (right) Corresponding radial inten­
sity histogram fitted with a Gaussian (red lines) to extract the indicated ra­
dius values. The ring radii measured in samples fixed with PFA is 45 ± 2 nm 
(n = 8), 45 ± 4 nm (n = 13) for MeOH­fixed samples, or 45 ± 3 nm (n = 21) 
for the sum of both. The black dotted lines mark the center of the Gaussian 
fit (red) of signal intensities, which is taken as the radius (indicated above). 
(B) Frequency of angular distribution on imaged HsSAS­6 rings as measured 
by peak­to­peak distance (n = 6 centrioles yielding 50 angular values; see 
also Fig. S4); means and standard deviations are indicated. (C) Model 
of HsSAS­6 C termini localization within the cartwheel. AU, arbitrary unit. 
Bars, 100 nm.
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Materials and methods
Cloning and mutagenesis
HsSAS­6 variants were cloned into a pENTR1A (Life Technologies) Gate­
way entry vector, modified by introducing restriction sites between the 
attR1­attR2 sites (5 AgeI and XbaI 3). HsSAS­6 inserts were generated by 
PCR (primers listed in Table S7), cloned into pENTR vectors using AgeI and 
XbaI, and sequence verified before Gateway recombination into the desti­
nation vectors pEBTet­GW­EGFP (FL and F131E) or pEBTet­EGFP­GW for all 
other constructs (Strnad, 2008).
The tagRFP–centrin­1 plasmid was generated by digesting pEGFP­
C1–centrin­1 (gift from M. Bornens, Institut Curie, Paris, France) with BamHI 
and Acc65I and ligating centrin­1 into these sites in pTagRFP­C (FP141; Ev­
rogen). The plasmid was digested with NheI and BamHI before ligation 
into pIRES­neomycin (gift from D. Gerlich, Institute of Molecular Biotechnol­
ogy, Vienna, Austria) and transfected into U2OS cells to generate stable 
cell lines.
Cell lines, RNAi, and synchronization
Cell line maintenance and generation. U2OS cells (European Collection of Cell 
Cultures) were maintained at 37°C and 5% CO2 in McCoy’s 5A GlutaMAX 
(Life Technologies) with 10% FBS or tetracycline­negative FBS (Chemie 
Brunschwig, AG) for the inducible episomal cell lines (iU2OS). iU2OS 
were generated by transfecting U2OS cells with pEBTet plasmids using 
Lipofectamine 2000 (Life Technologies) and selected with 1 µg/ml puromy­
cin. Induction was performed with 1 µg/ml doxycycline for 48 h. KE­37 
cells were maintained at 37°C and 5% CO2 in RPMl 1640 (Life Technolo­
gies) with 10% FBS.
RNAi. Depletion of HsSAS­6 with Stealth siRNA (3UTR, 5­GAGCU­
GUUAAAGACUGGAUACUUUA­3; Life Technologies) or of Cep152 with 
locked nucleic acid–based siRNAs (ORF, 5­GGAUCCAACUGGAAAUCU­
ATT­3; Life Technologies) was performed as previously reported (Kitagawa 
et al., 2011; Lukinavičius et al., 2013). Stealth RNAi siRNA Lo GC was 
used as a negative control (Life Technologies). To assess the function of 
HsSAS­6 constructs and when indicated, siHsSAS­6 3UTR treatment was 
concomitant to induction with doxycycline for 48 h.
Cell synchronization. Mitotic shake off was used to synchronize cells for 
detection of the FL­GFP torus, quantification of HsSAS­6 levels, and STORM 
imaging. For FRAP experiments, U2OS cells were synchronized by a double­
thymidine block (2 mM), doxycycline was added during the second thymi­
dine block, and samples were taken at successive time points after release 
from the block. No synchronization was performed for cells treated with si­
HsSAS­6 3UTR, but cells were binned according to their centriolar organiza­
tion in that case (see section Cell cycle stage determination).
Immunofluorescence and antibodies
Fixation. Cells were washed with PBS and fixed with methanol (Sigma­Aldrich) 
for 7 min at 20°C or with 2% formaldehyde (Thermo Fisher Scientific) 
in PBS for 20 min at room temperature. Samples were blocked in 5% BSA 
for 30 min before incubation for 2 h at room temperature with primary 
antibodies diluted in antibody solution (1% BSA­PBS and 0.2% Triton 
S phase, below the Kd expected to be required for oligomeriza-
tion. However, higher concentrations are likely achieved within 
centrosomal subvolumes, thus favoring N–N interaction and oligo-
merization. For instance, considering the torus size of 0.04 µm3 
determined by 3D-STORM, a maximum local molarity (i.e., as-
suming that all HsSAS-6 centrosomal proteins are in this sub-
volume) of 80 µM in early S would be achieved. Alternatively, 
proteins such as Cep135, which interacts with HsSAS-6 (Lin 
et al., 2013), or Plk4/ZYG-1, which is required for the robust 
presence of SAS-6 proteins at centrioles in human cells and in 
C. elegans (Strnad et al., 2007; Lettman et al., 2013), could help 
organize HsSAS-6 to favor oligomerization and incorporation 
within the nascent procentriole.
Superresolution methods uncovered the precise organi-
zation of several pericentriolar proteins (Lawo et al., 2012; 
Mennella et al., 2012; Sonnen et al., 2012) and the ninefold 
symmetrical organization of the appendage protein Cep164 
(Lau et al., 2012). However, the nanoscale organization of cart-
wheel proteins such as HsSAS-6 has remained elusive because 
of the minute size of this structure. Our 3D-STORM images 
provide the first visualization of ninefold symmetrical HsSAS-6 
rings at centrioles in the cellular context. Unexpectedly, STORM 
microscopy revealed a 2.5-fold increase in the length of stable 
HsSAS-6–containing structures between S and late G2 (Fig. 3, 
D–K), exceeding the 100-nm length of the cartwheel observed 
by EM in human cells (Guichard et al., 2010). This may reflect 
an unsuspected alteration in cartwheel size during procentriole 
formation or a fraction of stable HsSAS-6 present outside the 
cartwheel during late G2.
To conclude, we propose a model for HsSAS-6 assem-
bly during procentriole formation in human cells (Fig. 7). In this 
model, HsSAS-6 molecules are present primarily as homo-
dimers in the cytoplasm, before being recruited transiently around 
the parental centriole and then assembling into oligomers to form 
ninefold symmetrical rings in the cartwheel of the emerging pro-
centriole. Elucidating the mechanisms that regulate HsSAS-6 
assembly at each of these steps is expected to provide critical 
insight on how the evolutionarily conserved ninefold radial 
symmetry of centrioles is achieved.
Figure 7. Working model of HsSAS-6 distribution at centrosomes across the cell cycle. HsSAS­6 resides initially in the cytoplasm in a mixture of monomers 
and predominantly homodimers. During G1, HsSAS­6 is recruited around the parental centriole to a labile structure, the torus (blue), which coincides with 
Cep152 and Pericentrin. This localization might enable high enough HsSAS­6 concentrations to favor oligomerization, incorporation into a ninefold sym­
metrical ring structure, and initiation of cartwheel assembly. Throughout S–G2, progressive recruitment and immobilization of HsSAS­6 molecules into the 
assembling procentriole lead to the elongation of a stable HsSAS­6–positive structure, until a steady state of balanced exchange between centrosomal and 
noncentrosomal HsSAS­6 molecules is reached. See Discussion for additional details.
 o
n
 January 13, 2015
jcb.rupress.org
D
ow
nloaded from
 
Published March 3, 2014
709HsSAS-6–mediated centriole formation • Keller et al.
Image processing and quantification
Cell cycle stage determination. For both FRAP and HsSAS­6 levels analysis, 
cells were binned according to their centriolar organization, using centrin 
and HsSAS­6 distribution. The cell cycle stages were determined as fol­
lows: G1 (two centrin foci; no HsSAS­6), early S (two centrin foci; one or 
two HsSAS­6 foci), S–G2 (three to four close centrin foci; two HsSAS­6 
foci), and late G2 (four well­defined centrin foci; two HsSAS­6 foci, with 
separated diplosomes). For each cell, the signal was measured in Fiji, 
and the values of mean intensity (mean), total integrated intensity (sum), 
and area (area, in px) were recorded and used for quantification as de­
scribed and represented in Fig. S3 D.
Quantifying HsSAS-6 levels over the cell cycle. Cells were fixed with 
methanol, and stained for centrin­3 and HsSAS­6. Cells were binned in 
different cell cycle stages according to centriolar configurations and DNA 
condensation. The areas and quantification procedure used are illustrated 
in Fig. S3 D. Total HsSAS­6 cellular intensity was quantified by drawing 
a region (cell) over the entire cell, including the centrosome, and measur­
ing the mean intensity (MeanCell) and integrated intensity (SumCell) values. 
To remove microscope noise, the background was measured on areas out­
side the cells, and the mean value from 24 different such areas (MeanBG) 
from different coverslips was normalized to the cytoplasmic area and 
then subtracted from the total cytoplasmic intensity. Corrected cellular in­
tensity (CorrSumCell) refers to the intensity after background subtraction as 
shown on Fig. 4 E. For each cell, one to two centrosomal areas were 
drawn, and the centrin signal was used to assess whether the entire cen­
trosome was contained in the stacks. Centrosomal (PCM + centriole) in­
tensity was measured within a circular region of 20­px diameter (1.1 µm) 
on single centrosomes. Centrosomal intensity (IntCTM) was calculated by 
subtracting the mean cellular intensity (not background corrected) nor­
malized to centrosomal area from the centrosomal intensity (Fig. S3 D). 
As the centrosomal signal intensity represents 1% of the total cellular in­
tensity, including the former in the latter does not significantly affect the 
overall cellular intensity.
FRAP image processing and signal recovery quantification. To increase 
signal­to­noise ratio before quantification, the image was scaled by 0.5 
(final px size of 100 nm) and a Gaussian blur of  = 2 px was applied. 
Time points at which centrosomes were out of focus (judged by tagRFP– 
centrin­1) were excluded from the analysis. Centrosomes were identified 
using the centrin channel, and a circle of 22 px was used to measure cen­
trosomal signal. Quantification of signal recovery after photobleaching 
was performed in Fiji as represented in Fig. S3 D and described in the sec­
tion Quantifying HsSAS­6 levels over the cell cycle, but the centrosomal in­
tensity value (IntCTM) was further divided by the mean cytoplasmic intensity 
(unbleached) to account for photobleaching, yielding the normalized inten­
sity (NormIntCTL). Recovery points were fitted with a single exponential func­
tion: y = A(1  exp(t/)), yielding the maximum recovery amplitudes A 
and the time at half­maximal recovery t1/2 = ln(2) × .
Quantifying HsSAS-6 molecule numbers and molarity
Whole-cell extract (WCE) preparation. Exponentially growing U2OS or 
KE­37 cells were counted with a cell counter (ADAM; Digital Bio). WCEs 
from increasing cell numbers (50,000–2.5 million cells) were prepared in 
lysis buffer (section Cell extract preparation). The correlation between the 
number of cells used for the WCE and the protein concentration of the re­
spective extracts was determined. Increasing amounts of cells and of re­
combinant HsSAS­6 were loaded on a 10% polyacrylamide gel, and 
SDS­PAGE was performed.
Purified centrosome extracts. Centrosome preparations from KE­37 
cells were performed. Centrosomes were isolated from the lymphoblastic 
cell line KE­37 as described previously (Bornens et al., 1987). In brief, ex­
ponentially growing cells were treated with 200 nM nocodazole and 
1 µg/ml cytochalasin B and lysed 1 h thereafter in a low ionic strength buf­
fer in the presence of detergent. The lysate was cleared by centrifugation 
to eliminate cell debris and chromatin before isolation of centrosomes 
through centrifugation in a discontinuous sucrose gradient (40, 50, and 
70%). Fractions were collected, and the number of centrosomes in each 
fraction was estimated by immunofluorescence with centrosomal markers.
Expression and purification of GST–HsSAS-6. FL HsSAS­6 was expressed 
in Escherichia coli BL21(DE3) (Agilent Technologies) from a pGEX–HsSAS­6 
vector. Bacteria were grown at 37°C to an OD600 of 0.5 and then at 
30°C overnight after addition of IPTG to a final concentration of 1 mM. 
Two­step purification of GST–HsSAS­6 was performed using the Rapid GST 
Inclusion Body Solubilization and Renaturation kit (Cell Biolabs, Inc.) fol­
lowed by glutathione–Sepharose 4B beads (GE Healthcare) at 4°C. Washes 
X­100; Sigma­Aldrich). After washing (PBS–0.2% Triton X­100), the cover­
slips were incubated for 45 min with secondary antibodies. After washing, 
coverslips were mounted in glycerol­based mounting medium or kept at 
4°C in PBS with penicillin­streptomycin (Gibco) for STORM imaging.
Preextraction. Cells were preextracted for 30–60 s in 0.5% Triton 
X­100 in BRB80 (80 mM K­Pipes, 1 mM MgCl2, and 1 mM EGTA; all ob­
tained from Sigma­Aldrich), washed with PBS, and fixed with either metha­
nol or 2% PFA.
EdU labeling. 1 µM EdU was added to the cells for 15–60 min before 
fixation. EdU staining was performed using EdU Alexa Fluor 647 or Alexa 
Fluor 488 kit (Click­iT; Life Technologies) after antibody staining.
Antibodies. Primary antibodies for immunofluorescence were 1:4,000 
mouse centrin (20H5; gift from J.L. Salisbury, Mayo Clinic Foundation, 
Rochester, NY), 1:2,000 rabbit anti–centrin­3 (Middendorp et al., 2000; 
gift from M. Bornens), 1:2,000 rabbit Cep152 (HPA039408; Sigma­
Aldrich), 1:400 mouse CNAP­1 (611375; BD), 1:2,000 rabbit CP110 
(12780–1­AP; ProteinTech Europe), 1:500 rabbit anti­GFP (gift from V. Simanis, 
Swiss Federal Institute of Technology, Lausanne, Switzerland), 1:400 goat 
GFP (ab6673; Abcam), 1:500 mouse anti–HsSAS­6 (sc­81431; Santa Cruz 
Biotechnology, Inc.), 1:1,000 mouse PCNA (sc­56; Santa Cruz Biotechnol­
ogy, Inc.), and 1:1,000 goat Pericentrin (sc­28143; Santa Cruz Biotech­
nology, Inc.). Secondary antibodies, used at 1:1,000, were Alexa Fluor 
488, 568, or 647 (Life Technologies) for confocal imaging or Alexa Fluor 
647 F(ab)2 (A­21237; Life Technologies) for STORM imaging. DNA stain­
ing was performed with 1 µM Hoechst in PBS.
Cell extract preparation and Western blotting
Cell extract preparation. Extracts were prepared in lysis buffer (50 mM Tris­
HCl, pH 7.5, 0.5 mM EDTA, 0.5% NP­40, and 150 mM NaCl) in the pres­
ence of protease inhibitor cocktail cOmplete (Roche). Protein concentration 
was measured with the Bio­Rad Protein Assay kit (Bio­Rad Laboratories).
Western blotting. SDS­PAGE was performed using 4–15% or 10% 
polyacrylamide gels (Criterion; Bio­Rad Laboratories) followed by transfer 
onto nitrocellulose membrane (GE Healthcare). The membrane was probed 
with primary antibodies followed by incubation with HRP­conjugated sec­
ondary antibodies, and the signal was detected with chemiluminescence. 
Primary antibodies were mouse HsSAS­6 (1:1,000; sc­81431), mouse tu­
bulin (1:200,000; T5168; Sigma­Aldrich), and rabbit GFP (1:1,000; gift 
from V. Simanis). Rabbit or mouse HRP­conjugated secondary antibodies 
(65–6120 and 62–6520, respectively; Promega) were used at 1:5,000.
Microscopy
Confocal imaging. Imaging was performed on an upright confocal micro­
scope (LSM 710; Carl Zeiss) and using a 63× Plan Apochromat oil objec­
tive (differential interference contrast M27) with a 1.4 NA; the built­in 
filters main dichroic beam splitter 488/561/633 nm and main dichroic 
beam splitter 405 nm were used in the Frame Fast mode. 16­bit, 1,024 × 
1,024–pixel (px) images were taken with a dwell time of 0.64 µs/px using 
the ZEN software (Carl Zeiss). A px size of 55 nm, an optical section of 
0.7 µm, and z steps of 200 or 300 nm were taken, unless specified other­
wise. For high­resolution confocal imaging of the HsSAS­6 torus seen in 
Fig. 2 (A–D), a px size of 43 nm and a z step of 120 nm were taken with 
a 1.27­µs/px dwell time (speed 8) and a line average of 2; moreover, a 
Gaussian blur of  = 1 px was applied in Fiji, and single z planes were se­
lected for representation. For Fig. 2 (G–J) and Fig. S2 (K–P), a px size of 
170 nm and a z step of 100 nm were used with a 1.58­µs/px dwell time 
(speed 9) and a line average of 2.
FRAP. FRAP was performed using the ZEN software on an inverted 
confocal microscope (LSM 700; Carl Zeiss) and using a 63× Plan Apo­
chromat oil objective (differential interference contrast M27) with an NA of 
1.4. px sizes of 50 nm in xy and a z step of 500 nm were used for imag­
ing. The variable dichroic was set at 530 nm and long pass 560­nm and 
short pass 555­nm filters were used for the two photomultiplier tubes. Imag­
ing was performed in an equilibrated chamber at 37°C, 5% CO2, and the 
cell medium was changed before to phenol red–free Leibovitz’s medium 
(Life Technologies) containing doxycycline and supplemented with 10% 
FBS. A prebleach stack was acquired before photobleaching a 2.5­µm2 re­
gion comprising the centrosome using the 488­nm laser at 100% laser 
power for 250 ms. Subsequently, z stacks covering the cell were taken at 
a 1­min interval for 5 min, at a 5­min interval for 10 min, and at a 10­min 
interval for 30 min up to ≤45 min after photobleaching. Imaging was per­
formed at 1% 488­nm laser power and initially 1% 568­nm laser power 
(the 568­nm laser power was adjusted thereafter to correct for photo­
bleaching of tagRFP–centrin­1).
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configurations. Cells were preextracted, washed with PBS, fixed with 2% 
PFA or methanol, and immunostained as described in the section Immuno­
fluorescence and antibodies.
STORM imaging buffers preparation. Buffers were prepared as previ­
ously reported (Olivier et al., 2013a,b). For Fig. 2 (M–O) and Fig. 3 (G and H), 
depth­independent imaging was performed in Vectashield (Vector Labora­
tories) as in Olivier et al. (2013a). For Fig. 3 (D and E) and Fig. 6, HsSAS­6 
S­phase structures were imaged as in Olivier et al. (2013b), in a solution 
containing 10% (wt/vol) glucose in 10 mM Tris, pH 7.5, oxygen scaven­
gers (0.2 mg/ml glucose oxidase [Sigma­Aldrich] and 57 µg/ml catalase 
[Sigma­Aldrich]), and 10 mM mercaptoethylamine combined with 50 mM 
­mercaptoethanol and 2 mM cyclooctatetraene at pH 7–8.
STORM microscope and image analysis. 3D­STORM imaging and data 
analysis was performed as previously reported (Olivier et al., 2013a). In 
brief, imaging was performed on an inverted microscope (SR­200; Vutara), 
using a 60×/1.42 NA oil objective (UIS2 Plan Apochromat; Olympus). 
Extra magnification was used to achieve a px size of 101 nm on an elec­
tron multiplying charge­coupled device camera (Evolve 512; Photomet­
rics). A 647­nm laser (Coherent) was used for excitation, with a power of 
4.5 kW/cm2, and a 405­nm laser (CUBE; Coherent) for reactivation (few 
milliwatts/centimeter squared). Data were recorded at 25 frames per sec­
ond, and typical acquisitions consisted of 10,000–30,000 raw images.
Determination of HsSAS-6 structure length and volume. Images were 
projected on all three axes, and the appropriate orientation was chosen for 
measurements, using also centrin images acquired in wide field to help de­
termine this. Fluorescence intensities were sampled using a 200­nm­wide 
line profile, and values were plotted and then fitted with a single­ or double­
Gaussian function in OriginPro 8.6 software (OriginLab). The full width 
at half­maximum of a single­Gaussian fit or the sum of full width at half­
maximum for double­Gaussian fits were taken as length of the structure. 
Early stage structures were fit better with a single­Gaussian function, 
whereas for late G2 structures, a double­Gaussian function was more ap­
propriate. Volumes occupied by HsSAS­6 molecules were calculated by 
projecting the localized peaks on a 2D 10­nm grid along all three dimen­
sions, smoothing the images using an  = 10­nm Gaussian blur, and then 
thresholding the images as binary images and integrating the area cov­
ered by nonzero px. The three areas were then multiplied, and the square 
root of the result was used as the volume.
Determination of HsSAS-6 ring radii and angular distribution. To deter­
mine the radius of each HsSAS­6 ring and each F131E­EGFP torus, the lo­
calized peaks were rendered into a 3D stack of images, with each point 
represented by a Gaussian function ( = 4 nm; Peakselector; courtesy of 
H. Hess, Janelia Farm Research Campus, Howard Hughes Medical Insti­
tute, Ashburn, VA). The stack was then projected along the axis of the ring 
to yield a 2D image. The center of mass of each image was determined 
using ImageJ (National Institutes of Health), and the plugin Radial Profile 
was used to determine the intensity distribution as a function of distance 
from the center of mass, which was then fitted using a Gaussian function in 
OriginPro 8.6. Center positions values of each fitted Gaussian were taken 
as the ring radius. For Fig. 6, the angular distribution and fold symmetry of 
HsSAS­6 rings was assessed using the angular intensity profiles given by 
the plugin Oval Profile. The intensity profiles obtained were then filtered 
using a long pass Fourier filter in OriginPro 8.6, and peak­to­peak dis­
tances were calculated using local maxima (Fig. S4).
FCS
Sample preparation. We used iU2OS cell lines expressing GFP–GFP (55 kD), 
GFP­C (48 kD), FL­GFP, or F131E­GFP (both 103 kD) or U2OS transiently 
transfected with a pEBTet­GFP­GW construct, allowing the expression of 
a single GFP (as a result of a stop codon early in the Gateway recom­
bined sequence; 27 kD). Cells were plated in 35­mm glass­bottomed 
dishes (MatTek Corporation), and expression was induced 48 h before im­
aging. For FL­GFP, F131E­GFP, or GFP­C, endogenous HsSAS­6 was de­
pleted for 48 h concomitantly to the induction. Cells were kept at 37°C until 
imaging when the medium was changed to phenol red–free CO2­independent 
Leibovitz’s medium supplemented with 20% FCS, 2 mM glutamine, and 
100 mg/ml penicillin­streptomycin. Regular U2OS cells were used to mea­
sure background fluorescence and control for lack of autocorrelation of 
the signal.
FCS measurements. FCS measurements were performed with a micro­
scope (LSM 780 ConfoCor 3; Carl Zeiss). GFP and Alexa Fluor 488 fluor­
escent proteins (FPs) were excited with 488 nm from the built­in Ar ion 
laser. An acousto­optical tunable filter was used to adjust the incident irra­
diance after the microscope objective (40× C­Apochromat, NA 1.2, water 
were performed with 50 mM TrisHCl, pH 7.5, 300 mM NaCl, and 1 mM 
DTT complemented with proteinase inhibitor cocktail. Elution of the re­
combinant protein was performed with 50 mM glutathione, pH 7.5, 
and 500 mM NaCl.
Quantification of total cellular protein content. Western blotting was 
performed and the signal intensities of endogenous and recombinant 
HsSAS­6 were quantified with GelEval (FrogDance Software). Given that 
the signal intensities from recombinant HsSAS­6 correlated with known 
protein amounts, the total protein content for a given cell number could be 
then extrapolated. The calculation was performed as follows: from the 
amount of protein loaded (Fig. 4 G, protein, µg), we estimated the corre­
sponding cell number using the formulas indicated in Fig. 4 I (y = 10 × 
105x for U2OS, and y = 6 × 105x for KE­37, in which x = number of 
cells and y = micrograms of protein). Next, the signal intensity from the 
WCE blots (Fig. 4 G, WCE) was correlated to that of purified HsSAS­6 
protein by the formula specified in Fig. 4 H (y = 204,229x  65.7, in 
which x = quantification value [arbitrary unit] and y = micrograms of puri­
fied protein). Finally, these two values (number of cells and HsSAS­6 con­
tent) served to estimate the HsSAS­6 content per cell (expressed in 
picograms/cell), that being 0.044 pg in KE­37 and 0.055 pg in U2OS. 
To calculate the number of molecules per cell in U2OS, we converted the 
picograms/cell to molecules by taking into consideration HsSAS­6 molec­
ular mass (74 kD) and the Avogadro number and rounded up to the near­
est 1,000.
Estimating the fold enrichment of HsSAS-6 molecules at centrosomes. The 
signal intensity from the WCE and centrosome blots (Fig. 4 G) was corre­
lated to that of purified HsSAS­6 and corrected by the amount of protein 
loaded, yielding an HsSAS­6 fold enrichment of 61 ± 7–fold at centro­
somes versus WCE. In addition, we took into consideration that a typical 
U2OS asynchronous population has 50% of the cells in the G1, and from 
those, 70% do not display any HsSAS­6 centriolar signal (Fig. S3, A and B). 
Thus, we corrected for this population that was HsSAS­6 centriolar nega­
tive, resulting in the indicated 100­fold (98×) enrichment. Estimates in 
U2OS were also calculated using background­subtracted 3D confocal im­
ages (same as in Fig. 4, E and F) on which a Gaussian blur of  = 1 px 
was applied, comparing the maximum signal at centrosomes (1 px) to the 
mean cytoplasmic signal calculated from the mean intensity projection of 
the five innermost planes in the cell, yielding a value of 90 ± 27.
Estimating the molarity of HsSAS-6 molecules at centrosomes. The num­
ber of HsSAS­6 molecules in different cell cycle phases was estimated as 
follows. The number of molecules estimated via Western blotting (M) and 
the total fluorescence intensity (I) are linked by a conversion factor , 
whereby a given number of HsSAS­6 molecules M at a moment n corre­
sponds to a fluorescence intensity of I: Mn = In. It follows that the mean 
number of 500,000 HsSAS­6 molecules in WCE of asynchronously 
growing U2OS cell population represents the sum of molecules from the 
different cell cycle phases (M1, M2, and M3 in G1–S, S–G2, and late G2/M, 
respectively) pondered by the relative contribution of each phase (50% 
for G1/early S, 25% for S–G2, and 25% for late G2/M) giving the 
following equation: 0.5 M1 + 0.25 M2 + 0.25 M3 = 500,000. Similarly, 
the sum of the total HsSAS­6 fluorescence intensity (I1 in G1/early S, I2 for 
S–G2, and I3 for late G2/M) pondered by the fraction of the cell cycle 
gives the second equation: 0.5 I1 + 0.25 I2 + 0.25 I3 = 500,000. 
Solving these two equations yields the value for the conversion factor  
linking the fluorescence intensity to the number of HsSAS­6 molecules, 
whereby one HsSAS­6 molecule corresponds to a fluorescence intensity of 
I = 1/, i.e., 1/0.00135 or 740 arbitrary units. The number of HsSAS­6 
molecules in the cytoplasm was estimated using the measured mean total 
cellular fluorescence intensity at each cell cycle stages (Fig. 4 E) and the 
conversion factor. Similarly, numbers of molecules at centrosomes were es­
timated using the mean value of the measured total centrosomal intensity in 
Fig. 4 F, rounded up to the nearest 1,000. The corresponding cellular mo­
larity was calculated using a mean volume of 4,000 µm3 for a U2OS cell 
(assuming a spherical shape and a 20­µm diameter as in Beck et al., 
2011). A centrosomal volume of 0.2 µm3 was calculated from the optical 
resolution of the confocal images (1.4 NA and 600­nm emission wave­
length). As the aforementioned volume calculations are limited by the 
confocal resolution of our images, these numbers have to be considered 
as estimates.
STORM
STORM sample preparation. For HsSAS­6 staining, cells were plated on 18­mm 
size 1.5 precision coverslips (Carl Roth GmbH) cleaned overnight in 35% 
acetic acid/65% ethanol. Cells were synchronized by mitotic shake off, 
fixed at relevant times thereafter, and binned according to centrosome 
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of Kruskal–Wallis test ( = 0.05; Fig. 5 F). Table S7 shows primer names and 
sequences to generate specific entry vectors. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201307049/DC1.
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immersion; Carl Zeiss) below 2 kW/cm2 for the Ar ion laser (0.4% laser 
power) to reduce photobleaching and photophysical effects. Systematic 
determination of the lateral beam waist (0) of the focused laser and the 
structural parameter S was performed by measuring the translational diffu­
sion time constants D of 50 nM of soluble Alexa Fluor 488 (Life Technolo­
gies) with known diffusion coefficients D in aqueous solution (435 µm2/s) 
according to 0 = (4D × D)1/2. We obtained 0 = 204 nm and S = 5.5, 
yielding effective volumes of 0.3 fl. The values of S and 0 were kept con­
stant for the fitting of the different samples. Thereafter, fluorescence inten­
sity time traces and correlation curves of iU2OS cells, expressing either the 
different constructs, were recorded for 45 s. Cells with too high expression 
levels or presenting substantial fluorescence heterogeneity were not consid­
ered further.
FCS curve fitting and analysis. Autofluorescence was assessed on five 
untransfected U2OS cells and subtracted from all measurements before fit­
ting. Autocorrelation curves were generated and fitted as previously de­
scribed (Schmidt et al., 2009) using a model for one­ or two­component 
anomalous diffusion with proteinlike blinking (for GFP­containing proteins) 
or one­component anomalous diffusion with tripletlike blinking for Alexa 
Fluor 488 measurements. Initial fittings with a two­component model 
yielded a fraction of >97% of one component and <3% of a second much 
slower component (potentially reflecting cell movement) for all tested con­
structs (including GFP, known to diffuse as a single species). This analysis 
indicates that the one­component model is the most appropriate, which 
was thus used in all subsequent fittings. The goodness of the fit was esti­
mated by the R2 value of each fit. The following values were extracted from 
each autocorrelation curve and fit: mean number N of molecules in the ob­
servation volume determined from the ACF amplitude, their brightness 
(CPM), and their diffusion coefficients as given by the decay time of the fit­
ted ACF curve, D. The relative brightness (CPM) of each construct was first 
normalized to the mean value obtained for GFP. The mean relative bright­
ness (counts per second and CPM) normalized to the mean value obtained 
for GFP gave a value of 1.84 for GFP–GFP. This value indicates that the 
probability of each FP molecule to be in a fluorescent state is 0.92, most 
likely reflecting chromophore blinking and/or differences in maturation 
(Dickson et al., 1997; Haupts et al., 1998; Wachsmuth et al., 2000; 
Maeder et al., 2007). This affects the mean brightness of molecules and 
complexes, which carry more than one FP, whereas single FPs are either on 
or off. We thus corrected the brightness values for all constructs (except for 
the single GFP construct, as only on molecules are recorded) and reported 
them in Fig. 5 E. The diffusion coefficient was calculated from D using the 
equation D = 02/4 D. For each construct, these parameters were ana­
lyzed and plotted using Prism 6 (GraphPad Software).
Statistical analyses
All statistical analyses were performed using GraphPad Prism6, and the 
results and p­values of multiple comparisons performed are given in Tables 
S2–S6. For Fig. S2 (A and B), two­way analysis of variance (ANOVA) be­
tween control and siRNA­treated cells was performed including Sidak’s 
multiple comparisons ( = 0.05) at different time points and between treat­
ments. For the experiments in Fig. 4 and Fig. 5, normality of the population 
was assessed using D’Agostino and Pearson omnibus normality test ( = 
0.05). For the comparison of HsSAS­6 structure lengths and volumes be­
tween S–G2 and late G2 (Fig. 3, J and K), an unpaired two­tailed t test 
with Welch’s correction for unequal variance was performed with  = 0.05, 
yielding a P < 0.0001 for both. For multiple comparisons, conditions that 
exhibited a normal distribution (Fig. 4 F) were analyzed using an ordinary 
one­way ANOVA test and  = 0.05, and the p­values were corrected for 
multiplicity (Tukey’s test). For samples with nonnormal distribution or if one 
of the conditions did not exhibit a normal distribution (Fig. 4 E and Fig. 5, 
C and D), the nonparametric Kruskal–Wallis multiple comparison was per­
formed with  = 0.05, and the p­values were corrected for multiple com­
parisons (Dunn’s test).
Online supplemental material
Fig. S1 shows that HsSAS­6 variants are siRNA resistant and C­terminal speci­
ficity of the HsSAS­6 antibody. Fig. S2 shows the prevalence and localization 
of the torus for F131E­GFP and FL­GFP. Fig. S3 contains complementary data 
on quantification procedures and controls pertaining to Fig. 3 and Fig. 4. 
Fig. S4 describes the determination of the ninefold symmetrical organization 
of HsSAS­6 rings from 3D­STORM images. Table S1 contains cell numbers for 
Fig. 1. Table S2 shows cell numbers after shake off and results of two­way 
ANOVA (Fig. S2). Table S3 shows results of Kruskal–Wallis test ( = 0.05; 
Fig. 4 E). Table S4 shows results of ANOVA ( = 0.05; Fig. 4 F). Table S5 
shows results of Kruskal–Wallis test ( = 0.05; Fig. 5 E). Table S6 shows results 
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